AYM Syntex Limited has informed the Exchange about receipt of Observation Letters with no adverse observation from BSE Limited and National Stock Exchange of India Limited with regards to the Scheme of Amalgamation.
AYMSYNTEX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
AYM Syntex Limited has received 'no adverse observation' letters from both BSE and NSE on August 29, 2025 for its draft Scheme of Amalgamation with Mandawewala Enterprises Limited (MEL). Under the scheme, MEL (Transferor Company) will merge into AYM Syntex (Transferee Company) and their respective shareholders, under Sections 230-232 of the Companies Act, 2013. The original draft scheme was approved by the Board on February 6, 2025, with certain modifications approved later. The observation letters are valid for six months, within which AYM Syntex must file the scheme with the NCLT. SEBI has placed standard conditions including disclosure of share-swap ratio, financial details of both entities, shareholding pattern, rationale, risks, and pending legal actions before seeking shareholder approval.
This is a positive procedural milestone that clears the way for AYM Syntex to file the amalgamation scheme with the NCLT, moving the merger closer to completion. Shareholders should now look out for the NCLT filing, details of the share-swap ratio, and notices for shareholder and court meetings in the coming months.